Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.

Levy, Donald S; Farkas, Henriette; Riedl, Marc A; Hsu, Florence Ida; Brooks, Joel P; Cicardi, Marco; Feuersenger, Henrike; Pragst, Ingo; Reshef, Avner

Levy, Donald S; Farkas, Henriette; Riedl, Marc A; Hsu, Florence Ida; Brooks, Joel P; Cicardi, Marco; Feuersenger, Henrike; Pragst, Ingo; Reshef, Avner.

Afiliação

Levy DS; 1University of California-Irvine, Orange, 705 W La Veta Avenue, Suite 101, Orange, CA 92868 USA.
Farkas H; 2Hungarian Angioedema Reference Center, Third Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
Riedl MA; 3School of Medicine, University of California-San Diego, La Jolla, CA USA.
Hsu FI; 4Yale University School of Medicine, New Haven, CT USA.
Brooks JP; 4Yale University School of Medicine, New Haven, CT USA.
Cicardi M; 5IRCCS-ICS Maugeri Milano, University of Milan, Milan, Italy.
Feuersenger H; 6CSL Behring, Marburg, Germany.
Pragst I; 6CSL Behring, Marburg, Germany.
Reshef A; 7Allergy, Immunology and Angioedema Center, Barzilai Medical Center, Ashkelon, Israel.

Allergy Asthma Clin Immunol ; 16: 8, 2020.

Article em En | MEDLINE | ID: mdl-32042283

Palavras-chave

C1-inhibitor; Childbearing; Conception; Estrogen; Female; HAEGARDA; Hereditary angioedema; Pregnancy; Women

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Allergy Asthma Clin Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google